131 related articles for article (PubMed ID: 36576813)
41. Hepatectomy combined with sorafenib in patients with intermediate-advanced hepatocellullar carcinoma.
Zhu H; Ye B; Qiao Z; Zeng L; Li Q
J BUON; 2019; 24(4):1382-1389. PubMed ID: 31646781
[TBL] [Abstract][Full Text] [Related]
42. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.
Taura K; Ikai I; Hatano E; Fujii H; Uyama N; Shimahara Y
Ann Surg; 2006 Aug; 244(2):265-73. PubMed ID: 16858190
[TBL] [Abstract][Full Text] [Related]
43. Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort.
Maccali C; Chagas AL; Boin I; Quiñonez E; Marciano S; Vilatobá M; Varón A; Anders M; Hoyos Duque S; Lima AS; Menendez J; Padilla-Machaca M; Poniachik J; Zapata R; Maraschio M; Chong Menéndez R; Muñoz L; Arufe D; Figueroa R; Soza A; Fauda M; Perales SR; Vergara Sandoval R; Bermudez C; Beltran O; Arenas Hoyos I; McCormack L; Mattera FJ; Gadano A; Parente García JH; Tani CM; Augusto Carneiro D'Albuquerque L; Carrilho FJ; Silva M; Piñero F
Liver Int; 2021 Apr; 41(4):851-862. PubMed ID: 33217193
[TBL] [Abstract][Full Text] [Related]
44. Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study.
Jeon MY; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Lee JH; Yu SJ; Kim YJ; Yoon JH; Cho EJ; Kim SU
Gut Liver; 2020 Jul; 14(4):477-485. PubMed ID: 31640304
[TBL] [Abstract][Full Text] [Related]
45. Risk factors and clinical outcomes of extrahepatic recurrence in patients with post-hepatectomy recurrent hepatocellular carcinoma.
Li J; Huang L; Liu C; Qiu M; Yan J; Yan Y; Wei S
ANZ J Surg; 2021 Jun; 91(6):1174-1179. PubMed ID: 33724680
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial.
Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS
JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938
[TBL] [Abstract][Full Text] [Related]
47. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of surgical microwave ablation for recurrent hepatocellular carcinoma after curative hepatectomy.
Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
HPB (Oxford); 2020 Mar; 22(3):461-469. PubMed ID: 31473076
[TBL] [Abstract][Full Text] [Related]
49. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.
de'Angelis N; Landi F; Carra MC; Azoulay D
World J Gastroenterol; 2015 Oct; 21(39):11185-98. PubMed ID: 26494973
[TBL] [Abstract][Full Text] [Related]
50. Can IVIM help predict HCC recurrence after hepatectomy?
Zhang Y; Kuang S; Shan Q; Rong D; Zhang Z; Yang H; Wu J; Chen J; He B; Deng Y; Roberts N; Shen J; Venkatesh SK; Wang J
Eur Radiol; 2019 Nov; 29(11):5791-5803. PubMed ID: 30972544
[TBL] [Abstract][Full Text] [Related]
51. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
52. Recurrent hepatocellular carcinoma and poorer overall survival in patients undergoing left-sided compared with right-sided partial hepatectomy.
Valenzuela A; Ha NB; Gallo A; Bonham C; Ahmed A; Melcher M; Kim LH; Esquivel C; Concepcion W; Ayoub WS; Lutchman GA; Daugherty T; Nguyen MH
J Clin Gastroenterol; 2015 Feb; 49(2):158-64. PubMed ID: 24804988
[TBL] [Abstract][Full Text] [Related]
53. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?
Sotiropoulos GC; Drühe N; Sgourakis G; Molmenti EP; Beckebaum S; Baba HA; Antoch G; Hilgard P; Radtke A; Saner FH; Nadalin S; Paul A; Malagó M; Broelsch CE; Lang H
Dig Dis Sci; 2009 Oct; 54(10):2264-73. PubMed ID: 19057997
[TBL] [Abstract][Full Text] [Related]
54. Surgical treatment of extrahepatic recurrence of hepatocellular carcinoma.
Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
Langenbecks Arch Surg; 2014 Dec; 399(8):1057-64. PubMed ID: 25030500
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients.
Lise M; Bacchetti S; Da Pian P; Nitti D; Pilati PL; Pigato P
Cancer; 1998 Mar; 82(6):1028-36. PubMed ID: 9506346
[TBL] [Abstract][Full Text] [Related]
57. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
[TBL] [Abstract][Full Text] [Related]
58. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
59. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy.
Poon RT; Fan ST; O'Suilleabhain CB; Wong J
J Am Coll Surg; 2002 Sep; 195(3):311-8. PubMed ID: 12229937
[TBL] [Abstract][Full Text] [Related]
60. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
Sun JJ; Wang K; Zhang CZ; Guo WX; Shi J; Cong WM; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2016 Apr; 23(4):1344-51. PubMed ID: 26714945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
